Regulatory Hurdles For Decentralized Trials: A European Perspective
As COVID-19 began spreading across the globe, life sciences companies had to determine how to keep clinical trials running while making sure participants were safeOverview
Clinical Trial Management in a Post-Pandemic World
Last year, Informa Pharma Intelligence and Oracle surveyed the Life Sciences industry to understand the impact of the COVID-19 pandemic on clinical trial managementOverview
Has EDC Kept Up With Changes In Clinical Trials?
In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but today it can come from sources as varied as sensors, smartphones, and electronic health records (EHRs)
The Time Is Now For Transformation In Clinical Data Collection
When the COVID-19 pandemic began, many clinical trial teams were forced to quickly find remote methods for collecting data and conducting visits so they could keep patients safe and enrolled in trials that were already underway